Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if two different doses of AG1549 plus other anti-HIV
drugs are safe and effective in HIV-infected patients who are not taking anti-HIV drugs.
Phase:
Phase 2
Details
Lead Sponsor:
Agouron Pharmaceuticals
Treatments:
Anti-Retroviral Agents Capravirine Lamivudine Lamivudine, zidovudine drug combination Nelfinavir Zidovudine